EUR 77,21
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 87,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
EUR 86,33
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 92,41
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 92,45
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 93,33
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por Springer Verlag, Singapore, Singapore, 2026
ISBN 10: 9819590809 ISBN 13: 9789819590803
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 228,94
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications. This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 221,31
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 190,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications.
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 259,73
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Springer Verlag, Singapore, 2026
ISBN 10: 9819590809 ISBN 13: 9789819590803
Librería: Revaluation Books, Exeter, Reino Unido
EUR 281,91
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Brand New. 418 pages. 6.30x1.14x9.49 inches. In Stock.
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 85,66
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 89,63
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: CitiRetail, Stevenage, Reino Unido
EUR 82,79
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: CitiRetail, Stevenage, Reino Unido
EUR 92,46
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features: -Overcomes the blood-brain barrier using advanced delivery methods.-Improves drug penetration & specificity with nano and polymer-based systems.-Explores new therapies through immunotherapy, gene therapy, and personalised medicine.-Builds preclinical models & identifies biomarkers to support clinical success.-Designs regulatory-aligned clinical trial strategies for faster translation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Idioma: Inglés
Publicado por Springer Nature Singapore Jun 2026, 2026
ISBN 10: 9819590809 ISBN 13: 9789819590803
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 181,89
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications. 402 pp. Englisch.
Librería: moluna, Greven, Alemania
EUR 153,73
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt.
Librería: preigu, Osnabrück, Alemania
EUR 159,40
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. GPCR Dynamics | Unravelling the Complex Web of Signal Transduction | Prashant Tiwari (u. a.) | Buch | Emerging Paradigms in Pharmaceutical Research | xvi | Englisch | 2026 | Springer | EAN 9789819590803 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 181,89
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book offers a detailed exploration of G-protein-coupled receptors (GPCRs), key membrane proteins that mediate cellular responses to diverse signals. It covers GPCR activation, regulation, structural advances, technological innovations, and drug discovery, emphasizing their crucial roles in physiology and therapy. By integrating molecular insights with clinical applications, the book bridges basic science and translational research in GPCR biology.GPCRs function as vital cellular communication hubs by activating guanine nucleotide-binding proteins (G proteins) to transduce extracellular signals into intricate intracellular pathways. These signaling cascades regulate processes such as cell growth, gene expression, and intercellular communication, crucial for maintaining cellular homeostasis. Disruptions in GPCR signaling are linked to diverse pathologies, making them prime targets for therapeutic intervention.The book begins with GPCR structure and activation mechanisms, followed by signaling networks and receptor regulation. It then covers breakthroughs in structural biology and cutting-edge research technologies. Drug discovery strategies, including allosterism and biased signaling, are explored next. Systems biology and molecular pathologies provide deeper insights into GPCR functions and diseases. The final chapters focus on cellular toxicity, preclinical to clinical drug development, and future research challenges.This resource is designed for researchers and scientists in molecular pharmacology, cell biology, and drug discovery, as well as graduate and postgraduate students. Pharmaceutical industry professionals, educators, trainees, and healthcare professionals engaged in GPCR-targeted therapies will also find this book an essential guide to the latest advances and clinical applications.Springer Nature Customer Service Center GmbH, Europaplatz 3, 69115 Heidelberg 420 pp. Englisch.
Librería: CitiRetail, Stevenage, Reino Unido
EUR 231,49
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 283,57
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: CitiRetail, Stevenage, Reino Unido
EUR 271,38
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 329,09
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: preigu, Osnabrück, Alemania
EUR 281,55
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy | Prashant Tiwari (u. a.) | Taschenbuch | Englisch | 2025 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798337346281 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 290,40
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 406,00
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Neurodegenerative disorders pose a significant global health challenge, affecting millions of individuals and placing immense strain on families, healthcare systems, and economies. Advancements in understanding the underlying molecular mechanisms have opened new avenues for early diagnosis and targeted therapies. Innovative treatments like enzyme replacement and gene-editing technologies offer promising potential to slow disease progression and improve quality of life. These scientific breakthroughs not only enhance clinical care but also catalyze interdisciplinary collaboration across research, medicine, and policy. As society confronts aging populations and increasing neurological conditions, continued innovation in this field is crucial for sustainable, compassionate healthcare solutions. Recent Breakthroughs in Neurodegenerative Disorders and Enzyme Therapy explores molecular mechanisms, diagnostic, strategies, and therapeutic advancements for neurodegenerative conditions. Designed to bridge basic science and clinical applications, this book examines the role of lysosomal enzymes, advancements in gene-editing for enzyme delivery, and the translation of lab findings into real-world therapies. Covering topics such as artificial intelligence, neuroimaging, and radiation, this book is an excellent resource for neuroscientists, clinicians, medical researchers, biochemists, and more.